International Scholarly Research Notices / 2012 / Article / Tab 2

Research Article

Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans

Table 2

Vesicle size of niosomes.

Batch codeSize of niosome in μm
Without shaking
VS ± SD*
PI*With shaking
VS ± SD
PIAfter sonication
VS ± SD
PI

ES60A31.76 ± 1.410.0428.27 ± 1.520.0522.29 ± 1.960.08
ES60B33.19 ± 1.420.0430.17 ± 1.980.0623.41 ± 1.520.06
ES60C35.88 ± 1.960.0531.39 ± 0.960.0325.82 ± 2.220.08
ES60D24.10 ± 1.490.0621.30 ± 1.060.0516.02 ± 1.350.08
ES60E26.38 ± 1.520.0523.84 ± 1.790.0717.06 ± 1.160.06
ES60F29.00 ± 1.220.0425.55 ± 1.160.0421.20 ± 1.170.05
ES60G20.13 ± 2.330.1116.67 ± 1.760.1012.46 ± 0.780.06
ES60H22.31 ± 2.300.1019.96 ± 2.190.1113.15 ± 0.890.06
ES60I23.90 ± 1.540.0620.65 ± 1.780.0814.92 ± 1.420.09

*Mean of three separate observations ± standard deviation.
SD: standard deviation.
VS: mean vesicle size in μm.
PI: polydispersity index obtained as PI = (SD/VS).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.